Illumina Inc
Save
18.10B
Market cap
–
Current P/E
131.58x
Forward P/E
About
Health care
Sector
Diagnostics & Research
Industry
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest.
Similar securities
Based on sector and market capitalization
Report issue